HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest.

Abstract
Treatment of cancer cells with microtubule inhibitors causes mitotic arrest, which subsequently leads to cell death via activation of the intrinsic apoptotic pathway. Mitotically arrested cells typically display increased phosphorylation (i.e., inactivation) of two key anti-apoptotic proteins, Bcl-2 and Bcl-XL , but the mechanisms that regulate their phosphorylation as well as their role in apoptotic cell death following mitotic arrest are still poorly understood at present, which are the focus of this study. We recently showed that cyclin B1 and cell division cycle 2 (Cdc2) proteins are strongly up-regulated in human breast cancer cells following treatment with nocodazole (a prototypical microtubule inhibitor), and their up-regulation plays a critical role in the development of mitotic prometaphase arrest. In this study, we present evidence showing that the up-regulated cyclin B1/Cdc2 complex in nocodazole-treated human breast cancer cells is also responsible for the increased phosphorylation of Bcl-2 and Bcl-XL . However, only the increased phosphorylation of Bcl-XL , but not the phosphorylation of Bcl-2, contributes to subsequent activation of the intrinsic cell death pathway. In addition, evidence is presented to show that mitotic arrest deficient 2 (MAD2) is a key upstream mediator of the up-regulation of cyclin B1/Cdc2 as well as the subsequent increase in phosphorylationof Bcl-2 and Bcl-XL in nocodazole-treated cancer cells. Together, these results reveal that the up-regulated cyclin B1/Cdc2 complex not only mediates prometaphase arrest in nocodazole-treated cells, but also activates the subsequent intrinsic cell death pathway in these cells via increased phosphorylation of Bcl-XL .
AuthorsHye Joung Choi, Bao Ting Zhu
JournalMolecular carcinogenesis (Mol Carcinog) Vol. 53 Issue 2 Pg. 125-37 (Feb 2014) ISSN: 1098-2744 [Electronic] United States
PMID22949227 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2012 Wiley Periodicals, Inc.
Chemical References
  • BCL2L1 protein, human
  • Cyclin B
  • Cyclin B1
  • MAD2L1 protein, human
  • Mad2 Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein
  • CDC2 Protein Kinase
  • CDK1 protein, human
  • Cyclin-Dependent Kinases
  • Nocodazole
Topics
  • Apoptosis (drug effects, genetics)
  • CDC2 Protein Kinase
  • Cell Cycle Checkpoints (drug effects, genetics)
  • Cell Line, Tumor
  • Cyclin B (genetics)
  • Cyclin B1 (genetics)
  • Cyclin-Dependent Kinases
  • Humans
  • MCF-7 Cells
  • Mad2 Proteins (genetics)
  • Mitosis (drug effects, genetics)
  • Nocodazole (pharmacology)
  • Phosphorylation (drug effects, genetics)
  • Prometaphase (drug effects, genetics)
  • Proto-Oncogene Proteins c-bcl-2 (genetics)
  • Up-Regulation (drug effects)
  • bcl-X Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: